Clinical Trial Update: Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency [Phase 2]

View source ↗

Summary

Phase 2 trial examining paraurethral transplantation of autologous muscle-derived stem cells for treating stress urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Paraurethral Autologous Muscle-Derived Stem Cell Transplantation (Autologous muscle-derived stem cells for paraurethral transplantation)

Snippet

Sponsor: Royan Institute | Conditions: Stress Urine Incontinency | Phase 2 | Status: COMPLETED